More on LCTX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.84 |
|
|||
| Open | $1.94 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $1.95 | ||||
| Day Low | $1.81 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 1,692,029 | ||||
- H.C. Wainwright Reiterates Buy Rating on Lineage Cell Therapeutics Inc. (LCTX)
- Lineage Cell Therapeutics reports fourth quarter and 2025 results
- Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
- Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026
- Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience
- Lineage Cell Therapeutics outlines 2025 achievements and 2026 plans
- Lineage Cell Therapeutics Issues Letter to Stockholders
- Lineage Cell Therapeutics (LCTX) Misses Q3 EPS by 11c
- Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
- Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025
Entities mentioned with LCTX
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
